## **Core Concept**
Dezocine is an opioid analgesic drug that belongs to the class of mixed agonist-antagonist opioids. It acts primarily as a κ-opioid receptor agonist and a μ-opioid receptor partial agonist. This unique mechanism contributes to its analgesic effects and side effect profile.

## **Why the Correct Answer is Right**
The correct answer states that dezocine has a ceiling effect on respiratory depression. This is due to its action as a partial agonist at the μ-opioid receptor, which is responsible for the opioid-induced respiratory depression. Partial agonists have a ceiling effect on the response, meaning they do not produce the same level of effect as full agonists, even at higher doses. This characteristic makes dezocine potentially safer in terms of respiratory side effects compared to full μ-opioid receptor agonists.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because dezocine does not have a pure agonist profile at opioid receptors; it acts as a mixed agonist-antagonist.
- **Option B:** This option is incorrect because dezocine's mechanism does involve κ-opioid receptor agonism, not just μ-opioid receptor antagonism.
- **Option D:** This option is incorrect because dezocine does produce analgesia through its opioid receptor activity, specifically through κ-opioid receptor agonism and μ-opioid receptor partial agonism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember about dezocine is its potential to cause less respiratory depression compared to traditional opioid agonists, due to its partial agonist activity at the μ-opioid receptor. This makes it an interesting option for pain management, especially in settings where respiratory depression is a concern.

## **Correct Answer:** C.